Castle Biosciences Cash Flow Statement (2018-2026) | CSTL

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-8.79M	-11.79M	-13.38M	-24.62M	-1.65M	-20.25M	-20.62M	-29.20M	-18.78M	-6.91M	-2.58M	-2.53M	8.92M	2.27M	9.59M	-25.85M	4.52M	-0.50M	-2.33M	-14.52M
Depreciation and Depletion (Quarter)	0.38M	0.40M	0.44M	0.50M	0.53M	0.62M	0.63M	0.67M	0.79M	0.90M	0.95M	1.09M	1.10M	1.27M	1.43M	1.44M	1.45M	1.54M	1.50M	1.70M
Share-based Compensation (Quarter)	4.77M	5.21M	6.85M	8.42M	8.78M	9.20M	9.92M	13.53M	12.85M	13.04M	11.80M	12.68M	13.18M	13.03M	11.44M	11.18M	11.21M	12.10M	11.41M	9.78M
Deferred Taxes (Quarter)			-8.74M	0.12M	-1.96M		-0.04M	0.01M			-0.24M		-1.54M	5.25M	-2.31M	-0.77M	-4.67M	0.12M	-0.91M	-0.01M
Gains from Investment Securities (Quarter)			0.02M	0.02M	-20.40M	-0.15M	-4.22M	-0.21M		-0.07M		0.47M	-0.43M	-0.26M	8.97M	2.52M	-2.40M	4.17M	-4.17M	0.02M
Cash from Operations (Quarter)	-6.44M	-6.13M	-2.78M	-21.43M	-9.00M	-5.22M	-6.00M	-25.44M	-3.79M	5.01M	18.59M	-6.83M	24.00M	23.34M	24.36M	-6.04M	20.82M	22.63M	26.93M	-22.13M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)						0.18M	1.18M	1.23M	1.05M	1.57M	1.64M	1.70M	1.72M	1.65M	1.61M	1.44M	1.17M	0.91M	0.71M	0.45M
Amortization of Deferred Charges (Quarter)
Depreciation & Amortization (CF) (Quarter)	0.63M	1.09M	1.45M	2.15M	2.63M	2.92M	2.84M	2.89M	3.04M	3.17M	3.22M	3.34M	3.35M	3.54M	5.77M	29.76M	3.41M	3.82M	3.78M	3.93M
Change in Working Capital
Change in Receivables (Quarter)	3.72M	0.81M	-1.46M	2.73M	2.90M	0.05M	0.54M	4.38M	3.60M	5.80M	1.15M	4.26M	3.36M	4.25M	0.77M	5.22M	-3.91M	-1.91M	-6.27M	-1.07M
Change in Inventory (Quarter)	-0.32M	0.25M	-0.35M	0.33M	0.74M	0.44M	0.18M	0.54M	1.60M	-0.35M	2.17M	-0.30M	0.37M	-1.44M	1.56M	-1.29M	1.52M	0.31M	1.60M	0.21M
Change in Account Payables (Quarter)	-0.64M	1.36M	-0.85M	0.19M	0.12M	1.85M	-1.57M	3.90M	-0.82M	-0.38M	3.01M	-0.42M	-1.23M	-2.15M	-0.57M	0.61M	1.07M	1.41M	-0.02M	3.19M
Change in Accured Expenses (Quarter)	-0.19M	1.14M	1.67M	0.03M	-1.04M	0.16M	-0.11M	-11.56M	4.50M	8.44M	3.21M	0.07M	-0.01M	-1.34M	4.88M	1.14M	-0.67M	1.43M	3.83M	2.75M
Other Working Capital Changes (Quarter)	-1.05M	-4.00M	5.53M	-0.23M	0.93M	1.16M	-2.48M	-0.07M	0.15M	0.81M	-0.04M	0.23M	-0.66M	2.11M	-1.94M	3.36M	-4.23M	5.40M	-4.17M	0.53M
Investing Activities
Capital Expenditures (Quarter)	32.43M		-29.70M	0.03M	0.66M	3.15M	-2.45M	3.34M	-2.61M	9.10M	3.79M	0.70M	13.68M	6.38M	-20.76M	3.22M	3.60M	22.02M	-26.72M	12.46M
Sales of Property, Plant and Equipment (Quarter)		0.00M	0.00M		0.01M	0.00M	0.19M	0.01M	0.00M	0.00M	0.00M	0.01M	0.00M	0.00M	0.01M	0.01M	0.01M	0.02M	0.01M	0.01M
Acquisitions (Quarter)						0.30M
Change in Acquisitions & Divestments (Quarter)								50.00M	45.00M	43.00M	48.50M	50.20M	36.25M	36.80M	-123.25M	36.30M	44.00M	54.90M	54.00M	2.68M
Cash from Investing Activities (Quarter)	-34.09M	-0.92M	-30.89M	-0.40M	-27.51M	-134.15M	-4.48M	16.58M	-15.39M	-9.71M	-7.67M	-19.70M	-21.42M	-14.79M	5.77M	-22.43M	-28.38M	-18.39M	8.83M	-25.80M
Financing Activities
Other financing activities (Quarter)
Cash from Financing Activities (Quarter)	1.89M	1.89M	0.13M	1.22M	0.66M	0.39M	-0.75M	0.73M	0.23M	0.04M	-3.30M	10.64M	0.04M	0.84M	-5.38M	-1.55M	0.10M	-0.92M	-4.59M	-5.03M
Additional items
Change in Cash (Quarter)	-38.64M	-5.16M	-33.54M	-20.62M	-35.85M	-138.99M	-11.23M	-8.13M	-18.95M	-4.65M	7.62M	-15.89M	2.62M	9.39M	24.75M	-30.02M	-7.46M	3.32M	31.17M	-52.97M
Free Cash Flow (Quarter)	-38.87M	-6.13M	26.92M	-21.46M	-9.66M	-8.37M	-3.55M	-28.78M	-1.18M	-4.09M	14.79M	-7.53M	10.32M	16.96M	45.12M	-9.25M	17.22M	0.62M	53.65M	-34.58M
Net Cash Flow (Quarter)	-38.64M	-5.16M	-33.54M	-20.62M	-35.85M	-138.99M	-11.23M	-8.13M	-18.95M	-4.65M	7.62M	-15.89M	2.62M	9.39M	24.75M	-30.02M	-7.46M	3.32M	31.17M	-52.97M

Research Tools

Castle Biosciences Cash Flow Statement (2018-2026) | CSTL

Create an account

Sign In

Reset Password